We provide professional services to investors that share our vision of delivering better healthcare at lower costs to people with autoimmune & other chronic diseases. We help our clients advance virtual-first, digitally coordinated, patient-centered care across the spectrum of autoimmune and chronic immuno-inflammatory disorders. We approach all projects from a foundation of decades of experience in multiple areas of expertise.
Experience includes start-up co-founder (Yashi Care), practicing dentist, business & financial analyst, corporate & marketing communications, educated patient & advocate.
SME:
Autoimmune & immuno-inflammatory disease
Virtual-first, patient-centric care coordination & delivery
Lifestyle, functional & integrative modalities
Long covid & other post-viral syndromes
Oral & gut microbiome connection to systemic disease
Corporate & marketing communications
Biopharma/biotech, medical devices, healthcare IT
Our professional services include:
Autoimmune early stage investing & due diligence
Patient-centric care informed by patient advocacy
Financial background: Wall Street sell-side, buy-side, & investor relations professional.
Digital health, virtual-first, biotech, pharma & medical device consulting.
Our interest & expertise spans across healthcare silos, so necessary to improve autoimmune care.
How can we help you? Contact me for a free assessment of your needs & discussion of our capabilities.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Autoimmune Connect founded?
Autoimmune Connect was founded in 2023.
What industry is Autoimmune Connect in?
Autoimmune Connect operates in Business Consulting and Services. Find similar Business Consulting and Services investors on gritt.io.
Where is Autoimmune Connect based?
Autoimmune Connect is headquartered in Los Angeles, United States.
Find investors for your startup like Autoimmune Connect
Gritt sends AI-personalised outreach to each investor — from your Gmail
